A phase I trial of GKT 137831 for diabetic nephropathy in healthy volunteers
Phase of Trial: Phase I
Latest Information Update: 02 Nov 2012
At a glance
- Drugs GKT 831 (Primary)
- Indications Diabetic nephropathies
- Focus Adverse reactions; Pharmacokinetics
- 02 Nov 2012 Results have been reported in a Gekyotex media release.
- 02 Nov 2012 Status changed from active, no longer recruiting to completed based on information reported in a Genkyotex media release.
- 02 Nov 2012 Results have been presented at Kidney Week 2012, the annual meeting of the American Society of Nephrology, according to a Genkyotex media release. Results were also summarised in the media release.